Sure! Here's a comprehensive product information sheet for Brilliant Violet 650™ anti-human CD269 (BCMA):

---

Brilliant Violet 650™ Anti-Human CD269 (BCMA)

Product Description:
Brilliant Violet 650™ anti-human CD269 (BCMA) is a high-quality monoclonal antibody designed for the detection and analysis of B-cell maturation antigen (BCMA) on human cells. BCMA is a member of the TNF receptor superfamily and is predominantly expressed on plasma cells, playing a critical role in cell survival and proliferation. This antibody is conjugated to Brilliant Violet 650™, a bright fluorescent dye that provides superior performance in flow cytometry applications.

Key Features:
- High Specificity and Affinity: Specifically targets human BCMA with high affinity, ensuring accurate detection.
- Brilliant Violet 650™ Conjugation: Offers exceptional brightness and photostability, improving signal-to-noise ratio in flow cytometry assays.
- Optimized for Flow Cytometry: Provides clear and distinct population separation in multicolor flow cytometry panels.
- Clone: The antibody is derived from a specific clone, ensuring consistent performance and reproducibility.

Storage:
- Temperature: Store at 2-8°C. Do not freeze.
- Stability: The product is stable for at least 12 months from the date of receipt when stored as recommended.
- Handling: Protect from prolonged exposure to light. Briefly centrifuge the vial before opening to ensure maximum recovery of product.

What's Included:
- Antibody Solution: Brilliant Violet 650™ anti-human CD269 (BCMA) provided at a concentration optimal for flow cytometry applications.
- Safety Data Sheet (SDS): Detailed safety information and handling instructions.
- Product Information Sheet: Includes technical data, storage instructions, and application guidelines.

Applications:
- Flow Cytometry: Ideal for the identification and quantification of BCMA expression on human plasma cells and other cells of interest.
- Research on Plasma Cell Disorders: Useful in studies investigating multiple myeloma, chronic lymphocytic leukemia, and other conditions involving plasma cells.
- Immunophenotyping: Facilitates detailed immunophenotyping in research and clinical studies, contributing to a better understanding of immune cell populations.
- Target Validation: Supports target validation in the development of therapeutic interventions targeting BCMA.

---

This product information is designed to assist researchers and clinicians in effectively utilizing Brilliant Violet 650™ anti-human CD269 (BCMA) in their studies, providing reliable and reproducible results.